课题基金 / 基金详情

Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease

Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease
健康和疾病中控制淋巴血管功能的分子机制
批准号:
9310285
负责人:
Hong Chen
金额:
$78.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-05 至 2020-05-31

项目摘要

项目成果

Hong Chen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT The lymphatic system is essential in mediating tissue fluid homeostasis and intestinal lipid uptake. Importantly, lymphatic dysfunction positively correlates with body-mass index in morbidly obese patients accentuating the importance of the lymphatic system in maintaining metabolic homeostasis. In support, mice lacking one allele of Prox1 (a master regulator of lymphatic differentiation) develop adult onset obesity due to defective lymphatic vessels. How dysfunctional lymphatics aggravates metabolic syndrome, and conversely, how obesity impairs lymphatic function are poorly understood but highly medical relevant questions. This is highlighted by the fact that obese breast cancer patients undergoing lymphadenectomy are 3.6 times more prone to develop secondary lymphedema than non-obese breast cancer patients. Our long-term goal is to uncover molecular mechanisms governing lymphatic vascular function in health and disease and to identify critical regulators in hopes of offering potential new therapeutic targets to combat devastating metabolic disorders. We have identified two molecules that cooperatively regulate the pro-lymphangiogenic VEGFR3 signaling pathway. Using novel mouse models, we will determine whether manipulating these molecules will enhance the repair and regenerative response of lymphatic vessels after challenges such as lymphadenectomy and high fat diet. We will use sensitive imaging approaches and clinically relevant mouse models to address our questions. Specifically, we will determine molecular mechanism by which Foxc2 regulates lymphatic function in adult mice and define the regulatory machinery controlling the expression of Foxc2 and epsin in lymphatic endothelial cells. Finally, we will test the therapeutic potential of targeting Foxc2 or epsin in lymphatic dysfunctions. In summary, our findings could translate into innovative approaches to treat lymphatic dysfunctions and metabolic disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sonogenetics 2.0
  • 批准号:
    10734960
  • 项目类别:
  • 资助金额:
    $64.14万
  • 财政年份:
    2023
  • 负责人:
    Hong Chen
  • 依托单位:
Role of PXR in drug-elicited cardiovascular disease
Sonobiopsy for Noninvasive Genetic Evaluation of Glioblastoma Patients
  • 批准号:
    10564014
  • 项目类别:
  • 资助金额:
    $65.12万
  • 财政年份:
    2022
  • 负责人:
    Hong Chen
  • 依托单位:
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis
  • 批准号:
    10532247
  • 项目类别:
  • 资助金额:
    $76.94万
  • 财政年份:
    2021
  • 负责人:
    Hong Chen
  • 依托单位:
海外基金